Optimizing Therapy for Patients Radioactive Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) : Episode 8
Opinion
Video
Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression
The panel discusses the importance of thyroid hormone replacement and TSH suppression, highlighting the role of endocrinologists in managing the risk of cardiovascular disease. Dr. Brose also addresses the potential long-term risks associated with radioactive iodine treatment in the post-surgery setting, including cytopenia, salivary gland issues, and excessive tearing of the eyes.
Latest CME
View All
Video
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Apr 23rd 2025 - Apr 24th 2026
online-activity
Video
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Apr 23rd 2025 - Apr 24th 2026
online-activity
Video
Addressing Unmet Needs in HER2+ Metastatic BTC
Apr 18th 2025 - Apr 19th 2026
online-activity
Related Content
.png?fit=crop&auto=format)
